M. Seferoglu Et Al. , "MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine," NEUROLOGICAL SCIENCES , vol.42, no.9, pp.3533-3535, 2021
Seferoglu, M. Et Al. 2021. MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine. NEUROLOGICAL SCIENCES , vol.42, no.9 , 3533-3535.
Seferoglu, M., Ethemoglu, O., TURAN, Ö. F., & SİVA, A., (2021). MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine. NEUROLOGICAL SCIENCES , vol.42, no.9, 3533-3535.
Seferoglu, Meral Et Al. "MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine," NEUROLOGICAL SCIENCES , vol.42, no.9, 3533-3535, 2021
Seferoglu, Meral Et Al. "MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine." NEUROLOGICAL SCIENCES , vol.42, no.9, pp.3533-3535, 2021
Seferoglu, M. Et Al. (2021) . "MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine." NEUROLOGICAL SCIENCES , vol.42, no.9, pp.3533-3535.
@article{article, author={Meral Seferoglu Et Al. }, title={MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine}, journal={NEUROLOGICAL SCIENCES}, year=2021, pages={3533-3535} }